Target Price | $179.01 |
Price | $151.40 |
Potential | 18.24% |
Number of Estimates | 29 |
29 Analysts have issued a price target Procter & Gamble 2026 . The average Procter & Gamble target price is $179.01. This is 18.24% higher than the current stock price. The highest price target is $195.30 29.00% , the lowest is $145.65 3.80% . | |
A rating was issued by 35 analysts: 23 Analysts recommend Procter & Gamble to buy, 12 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2026 of 18.24% . Most analysts recommend the Procter & Gamble stock at Purchase. |
28 Analysts have issued a sales forecast Procter & Gamble 2026 . The average Procter & Gamble sales estimate is $89.6b . This is 6.25% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $92.1b 9.24% , the lowest is $83.7b 0.71% .
This results in the following potential growth metrics:
2025 | $84.3b | 0.29% |
---|---|---|
2026 | $89.6b | 6.25% |
2027 | $92.3b | 3.06% |
2028 | $95.5b | 3.45% |
2029 | $98.4b | 3.11% |
2030 | $102b | 3.86% |
2031 | $105b | 2.31% |
2032 | $109b | 3.85% |
24 Analysts have issued an Procter & Gamble EBITDA forecast 2026. The average Procter & Gamble EBITDA estimate is $25.1b . This is 6.10% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $26.5b 11.99% , the lowest is $23.4b 1.09% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $23.6b | 1.87% |
---|---|---|
2026 | $25.1b | 6.11% |
2027 | $26.3b | 4.82% |
2028 | $27.3b | 4.08% |
2029 | $28.1b | 2.60% |
2030 | $29.1b | 3.81% |
2031 | $29.1b | 0.04% |
2032 | $30.4b | 4.22% |
2025 | 28.02% | 1.58% |
---|---|---|
2026 | 27.99% | 0.12% |
2027 | 28.46% | 1.68% |
2028 | 28.64% | 0.63% |
2029 | 28.50% | 0.49% |
2030 | 28.48% | 0.07% |
2031 | 27.85% | 2.21% |
2032 | 27.95% | 0.36% |
27 Procter & Gamble Analysts have issued a net profit forecast 2026. The average Procter & Gamble net profit estimate is $16.9b . This is 7.67% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $17.5b 11.31% , the lowest is $15.9b 1.10% .
This results in the following potential growth metrics and future Net Margins:
2025 | $15.7b | 7.45% |
---|---|---|
2026 | $16.9b | 7.67% |
2027 | $17.9b | 6.02% |
2028 | $18.9b | 5.38% |
2029 | $19.4b | 2.66% |
2030 | $20.4b | 5.24% |
2031 | $20.9b | 2.37% |
2032 | $22.1b | 6.13% |
2025 | 18.61% | 7.14% |
---|---|---|
2026 | 18.85% | 1.31% |
2027 | 19.40% | 2.92% |
2028 | 19.76% | 1.86% |
2029 | 19.67% | 0.46% |
2030 | 19.93% | 1.32% |
2031 | 19.95% | 0.10% |
2032 | 20.39% | 2.21% |
27 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble EPS is $7.20 . This is 12.32% higher than earnings per share in the financial year 2025. The highest EPS forecast is $7.44 16.07% , the lowest is $6.76 5.46% .
This results in the following potential growth metrics and future valuations:
2025 | $6.38 | 8.14% |
---|---|---|
2026 | $7.20 | 12.85% |
2027 | $7.64 | 6.11% |
2028 | $8.05 | 5.37% |
2029 | $8.26 | 2.61% |
2030 | $8.69 | 5.21% |
2031 | $8.90 | 2.42% |
2032 | $9.45 | 6.18% |
Current | 23.62 | 21.45% |
---|---|---|
2026 | 21.02 | 11.00% |
2027 | 19.83 | 5.66% |
2028 | 18.82 | 5.09% |
2029 | 18.33 | 2.60% |
2030 | 17.42 | 4.96% |
2031 | 17.01 | 2.35% |
2032 | 16.03 | 5.76% |
Based on analysts' sales estimates for 2026, the Procter & Gamble stock is valued at an EV/Sales of 4.24 and an P/S ratio of 3.96 .
This results in the following potential growth metrics and future valuations:
Current | 4.50 | 11.59% |
---|---|---|
2026 | 4.24 | 5.88% |
2027 | 4.11 | 2.97% |
2028 | 3.97 | 3.33% |
2029 | 3.85 | 3.02% |
2030 | 3.71 | 3.72% |
2031 | 3.63 | 2.26% |
2032 | 3.49 | 3.71% |
Current | 4.20 | 12.45% |
---|---|---|
2026 | 3.96 | 5.88% |
2027 | 3.84 | 2.97% |
2028 | 3.71 | 3.33% |
2029 | 3.60 | 3.02% |
2030 | 3.47 | 3.72% |
2031 | 3.39 | 2.26% |
2032 | 3.26 | 3.70% |
Procter & Gamble...
Analyst | Rating | Action | Date |
---|---|---|---|
JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Oct 10 2025 |
B of A Securities |
Buy
➜
Buy
|
Unchanged | Oct 08 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Oct 08 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 01 2025 |
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Sep 25 2025 |
BNP Paribas |
Outperform
➜
Outperform
|
Unchanged | Aug 15 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jul 31 2025 |
Analyst Rating | Date |
---|---|
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Oct 10 2025 |
Unchanged
B of A Securities:
Buy
➜
Buy
|
Oct 08 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Oct 08 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Oct 01 2025 |
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Sep 25 2025 |
Unchanged
BNP Paribas:
Outperform
➜
Outperform
|
Aug 15 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Jul 31 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.